| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T51 |
0-61 |
Sentence |
denotes |
In the world of Covid-19 and vaccines, many questions remain. |
| T52 |
62-148 |
Sentence |
denotes |
What are the correlates of protective immunity after natural infection or vaccination? |
| T53 |
149-177 |
Sentence |
denotes |
How long will immunity last? |
| T54 |
178-251 |
Sentence |
denotes |
Will widespread immunity limit the spread of the virus in the population? |
| T55 |
252-321 |
Sentence |
denotes |
Which component of the vaccine is responsible for allergic reactions? |
| T56 |
322-409 |
Sentence |
denotes |
Are some vaccines less likely than others to cause IgE- and non-IgE–mediated reactions? |
| T57 |
410-639 |
Sentence |
denotes |
Careful vaccine-safety surveillance over time, paired with elucidation of mechanisms of adverse events across different SARS-CoV-2 vaccine platforms, will be needed to inform a strategic and systematic approach to vaccine safety. |
